Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Zoetis Inc ZTS

Healthcare
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a... see more

NYSE:ZTS - Post Discussion

Zoetis Inc > Outperform Recommendation Issued On ZTS By William Blair
View:
Post by whytestocks on Apr 12, 2024 6:00pm

Outperform Recommendation Issued On ZTS By William Blair

NEWS: $ZTS Outperform Recommendation Issued On ZTS By William Blair2024-04-12 13:30:03 ET William Blair analyst issues OUTPERFORM recommendation for ZTS on April 12, 2024 12:11PM ET. The previous analyst recommendation was Outperform. ZTS was trading at $149.635 at issue of the analyst recommendation. The overall analyst consensus : BUY...ZTS - Outperform Recommendation Issued On ZTS By William Blair
Be the first to comment on this post
Zoetis Inc